Call to arrange a consultation
+1 416 777 0888

Fournier Pharma Inc. v. Sandoz Canada Inc. et al.

Represented Sandoz Canada Inc. in a proceeding under the Patented Medicines (Notice of Compliance) Regulations regarding the invalidity and non-infringement of patents relating to Fournier's Lipidil EZ (fenofibrate) product.  The dismissal of Fournier's application is reported at 2012 FC 740.

Meet the team